Is Pemetrexed Disodium Injection (Alimta) in shortage?
Pemetrexed Disodium Injection is listed by FDA as being discontinued by at least one maker (updated Oct 16, 2025).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Alimta, Injection, 500 mg/20 mL (NDC 0002-7623-01)
Discontinuation of the manufacture of the drug
Maker contact: 800-545-5979
- Alimta, Injection, 100 mg/4 mL (NDC 0002-7640-01)
Discontinuation of the manufacture of the drug
Maker contact: 800-545-5979
- Pemetrexed Disodium, Injection, 100 mg/4 mL (NDC 0781-3518-76)
Discontinuation of the manufacture of the drug
Maker contact: 800-525-8747
- Pemetrexed Disodium, Injection, 500 mg/20 mL (NDC 0781-3519-90)
Discontinuation of the manufacture of the drug
Maker contact: 800-525-8747
Pemetrexed Disodium Injection shortage questions
Is Pemetrexed Disodium Injection (Alimta) in shortage?
Pemetrexed Disodium Injection is listed by FDA as being discontinued by at least one maker (updated Oct 16, 2025).
What should I do if I can’t get Pemetrexed Disodium Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.